A Study to Investigate the Safety, Tolerability, Pharmacokinetics, and Anti-tumor Activity of CBI-1214 T Cell Engager in Participants With Advanced or Metastatic MSS/MSI-L Colorectal Cancer

计划入组 80 人 · 首次发布于 2026 年 1 月 6 日

Cognitive Behavioral Immersion: A Randomized Control Trial of Peer-Based Coaching in the Metaverse

计划入组 306 人 · 首次发布于 2024 年 5 月 17 日

Compassion-Based Intervention for Lung Cancer Caregivers (CBI-LCC)

计划入组 84 人 · 首次发布于 2025 年 4 月 16 日

CBI-101

CBI-009

CBI-008

XIAONAN CUI

Australia

CTI BIOPHARMA

United States

CBIO LIMITED

The Bahamas

FDA Approves IND and Grants Fast Track Designation for CBI-1214 T-Cell Engager in Colorectal Cancer

Cartography Biosciences Raises $67M Series B to Advance Novel T-Cell Engager for Colorectal Cancer

Long-term Benefits of Dose-dense Adjuvant Chemotherapy in Early Breast Cancer Patients